(Q33923147)

30 July 2017

A trial of intrapleural adenoviral-mediated Interferon-α2b gene transfer for malignant pleural mesothelioma (English)

1 reference

malignant pleural mesothelioma

30 July 2017

1 reference

1 reference

Sharyn I Katz

7

0 references

Daniel Sterman

object named as

Daniel H Sterman

1

0 references

Carl H. June

17

object named as

Carl H June

1 reference

30 July 2017

Andrew Haas

2

1 reference

30 July 2017

Edmund Moon

3

1 reference

30 July 2017

Adriana Recio

4

1 reference

30 July 2017

Daniel Schwed

5

1 reference

30 July 2017

Anil Vachani

6

1 reference

30 July 2017

Colin T Gillespie

8

1 reference

30 July 2017

Guanjun Cheng

9

1 reference

30 July 2017

Jing Sun

10

1 reference

30 July 2017

Emmanouil Papasavvas

11

1 reference

30 July 2017

Luis J Montaner

12

1 reference

30 July 2017

Daniel F Heitjan

13

1 reference

30 July 2017

Leslie Litzky

14

1 reference

30 July 2017

Joseph Friedberg

15

1 reference

30 July 2017

Melissa Culligan

16

1 reference

30 July 2017

Richard G Carroll

18

1 reference

30 July 2017

Steven M Albelda

19

1 reference

30 July 2017

language of work or name

English

0 references

publication date

3 June 2011

1 reference

American Journal of Respiratory and Critical Care Medicine

30 July 2017

1 reference

30 July 2017

184

1 reference

30 July 2017

12

1 reference

30 July 2017

1395-1399

1 reference

Chemotherapy delivered after viral immunogene therapy augments antitumor efficacy via multiple immune-mediated mechanisms

30 July 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3262033

A phase I trial of repeated intrapleural adenoviral-mediated interferon-beta gene transfer for mesothelioma and metastatic pleural effusions

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3262033

Protein arrays as tools for serum autoantibody marker discovery in cancer

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3262033

Conditioned medium from Ad-IFN-alpha-infected bladder cancer and normal urothelial cells is cytotoxic to cancer cells but not normal cells: further evidence for a strong bystander effect

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3262033

Advances in the systemic therapy of malignant pleural mesothelioma

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3262033

A phase I clinical trial of single-dose intrapleural IFN-beta gene transfer for malignant pleural mesothelioma and metastatic pleural effusions: high rate of antitumor immune responses

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3262033

Cytokine gene therapy for malignant pleural mesothelioma.

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3262033

Inquiring into the differential action of interferons (IFNs): an IFN-alpha2 mutant with enhanced affinity to IFNAR1 is functionally similar to IFN-beta

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3262033

Advances in the diagnosis, evaluation, and management of malignant pleural mesothelioma

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3262033

Interferon in oncological practice: review of interferon biology, clinical applications, and toxicities

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3262033

Differences in interferon alpha and beta signaling. Interferon beta selectively induces the interaction of the alpha and betaL subunits of the type I interferon receptor

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3262033

Differential antiproliferative activities of IFNs alpha, beta and gamma: kinetics of establishment of their antiproliferative effects and the rapid development of resistance to IFNs alpha and beta.

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3262033

Interferon beta adenoviral gene therapy in a patient with ovarian cancer.

5 July 2018

1 reference

Crossref

https://api.crossref.org/works/10.1164%2FRCCM.201103-0554CR

Interferon-alpha2b secretion by adenovirus-mediated gene delivery in rat, rabbit, and chimpanzee results in similar pharmacokinetic profiles

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1164%2FRCCM.201103-0554CR

Cycloxygenase-2 inhibition augments the efficacy of a cancer vaccine

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1164%2FRCCM.201103-0554CR

Use of cyclooxygenase-2 inhibition to enhance the efficacy of immunotherapy.

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3262033

Comparison of gene expression patterns induced by treatment of human umbilical vein endothelial cells with IFN-alpha 2b vs. IFN-beta 1a: understanding the functional relationship between distinct type I interferons that act through a common receptor

29 October 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/21642245

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1164/RCCM.201103-0554CR

1 reference

30 July 2017

1 reference

30 July 2017

1 reference